Dezandrodeg (INN, USAN; developmental code names BMS-986365 and CC-94676) is an antiandrogen which is under development for the treatment of prostate cancer. It is taken orally.
The compounds of every Wikipedia article carrying a Chembox or a Drugbox, refreshed daily, with the values their infoboxes give. The pages need JavaScript; the API does not.